Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Disease

Life-threatening disease linked to tick bites found at popular UK beauty spots

The new cases brings the total of UK-acquired cases to six

The Independent UK

Lyme disease cases in England rise by more than 20% in a year

Scientists developing vaccines and anti-tick treatments amid growing concern over spread of disease

The Guardian - UK

Climb Bio Teases Key Budoprutug, CLYM116 Readouts at BioConnect

Climb Bio (NASDAQ:CLYM) outlined its clinical development strategy and upcoming data readouts during a fireside chat at H.C. Wainwright’s BioConnect Conference, with management emphasizing two biologic drug programs aimed at immune-mediated diseases, including nephrology and hematology indications.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Why diphtheria, whooping cough and measles have come back in Australia

Diphtheria was once one of Australia’s most feared childhood infections, killing thousands of children before vaccines were available. Then for decades, it became so rare most doctors never saw a case.

The Conversation

FED:Remote health staff plea as disease outbreak spreads

Australia's worst diphtheria outbreak in decades highlights a shortfall in health workers in remote communities as a multimillion-dollar package is announced.

AAP

CG Oncology Touts Bladder Cancer Data, Q4 Filing Plans at RBC Conference

CG Oncology (NASDAQ:CGON) executives used an RBC Capital Markets fireside chat to outline recent clinical data for cretostimogene, the company’s investigational therapy for non-muscle invasive bladder cancer, and to discuss upcoming regulatory, manufacturing and commercial milestones. The discussio

MarketBeat

The Ebola and hantavirus outbreaks warn us we must be better prepared if we are to prevent the next pandemic

Surveillance that misses a haemorrhagic fever or fails to consider endemic risks at a departure port will be blind to something far more dangerous

The Guardian - AU

Read news from The Economist, FT, and more,
with one subscription

Belite Bio Q1 Earnings Call Highlights

Belite Bio (NASDAQ:BLTE) said it has begun a rolling New Drug Application submission to the U.S. Food and Drug Administration for Tinlarebant in Stargardt disease, while also accelerating preparations for a potential commercial launch. On the company’s first-quarter 2026 earnings call, Chairman and

MarketBeat

'Most kids don't survive 12 months': big questions about a horrible disease

Researcher delves into the origins of cancer.

Newcastle Herald

Blood biomarkers could detect earliest signs of Alzheimer’s disease – and slow its progression

Alzheimer’s disease, a progressive neurodegenerative disorder that affects millions worldwide, has a long preclinical stage. It potentially begins decades before clinical symptoms become apparent.

The Conversation

Experts suggest heart disease risk may start as early as in the womb

Cardiovascular disease is the leading cause of death in America, resulting in nearly 920,000 deaths a year

The Independent UK

Beam Therapeutics Eyes Sickle Cell BLA as Alpha-1 Gene-Editing Program Advances

Beam Therapeutics (NASDAQ:BEAM) Chief Executive Officer John Evans said the company is advancing its base-editing platform across hematology and liver disease programs, with a potential biologics license application for its sickle cell disease candidate possible as early as the end of this year. Sp

MarketBeat

The Guardian view on tackling Ebola: pathogens aren’t the only things that kill

Editorial: Conflict and aid cuts are hampering the fight against an outbreak of the deadly virus centred in the Democratic Republic of the Congo

The Guardian - UK

Mirum Pharma: A Rare Disease Growth Story to Watch

Mirum stock pulled back after earnings despite strong growth. Here’s why investors still see upside in the rare disease biotech company

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Why managing expectations matters in chronic pain treatment

In a 2026 study I conducted with colleagues on people with peripheral arterial disease, one participant described how leg pain had disrupted his golf for years. It forced him to stop mid-round, shake his leg and apologise to his playing partners while he waited for the pain to pass. He…

Saving Advice

Why More Young Americans Are Being Diagnosed With Heart Disease

For decades, heart disease was viewed as a problem that mostly affected retirees and older adults, but doctors are now seeing a troubling shift in...

Salon

Ebola outbreak is a US failure

America didn't cause these diseases. But Trump’s cuts to public health have put the world at risk

MarketBeat

Immunovant Q4 Earnings Call Highlights

Roivant executives used the company’s fourth-quarter and fiscal-year earnings call to highlight new clinical data from its development portfolio, upcoming readouts and its strengthened balance sheet following a settlement with Moderna. Matthew Klein, CEO of Roivant, said the company has had “a pret

Get all your
news in one place.

100's of premium titles.
One news app.

Radio France Internationale

United States to fund Ebola clinics as aid cuts blamed for spread of virus

Ebola cases continued to rise in the Democratic Republic of Congo on Wednesday as the United States pledged to fund up to 50 treatment clinics and aid groups blamed earlier US funding cuts for weakening disease surveillance in the region.

AAP

Pictor and Disease Research Limited Formalise Collaboration to Advance Johne's Disease Monitoring Across New Zealand

AUCKLAND, New Zealand, May 20, 2026 /PRNewswire/ -- Pictor, a global targeted proteomics platform company founded in New Zealand, today announced it has formalised a collaboration with Disease Research Limited (DRL), a leading New Zealand veterinary diagnostic laboratory based at Invermay Research Centre in Mosgiel, Dunedin. The collaboration formalises an…

The Conversation

How employers can support workers when they take medical leave

Car crash. Cancer diagnosis. Mental health crisis. Autoimmune disease flareup.

The Guardian - UK

Vaccine to tackle Ebola outbreak will take six to nine months, says WHO

The response to the current wave of the disease, which has caused 139 deaths in central Africa to date, has been hampered by security concerns

The Independent UK

Australia struggles to contain worst diphtheria outbreak in decades after over 220 cases reported

Health authorities say almost all cases involve Indigenous Australians

The Times of India

Ebola returns: How this outbreak is different from before

A concerning outbreak of a unique Bundibugyo Ebola strain has emerged in the Democratic Republic of Congo, with reports of cases now reaching Uganda. In the absence of an effective vaccine or treatment, public health leaders are mobilizing international efforts to combat the crisis.

AAP

FED:'Concerning outbreak': respiratory disease cases rising

Case numbers in one of Australia's worst diphtheria outbreaks are climbing, with Prime Minister Anthony Albanese joining the call for people to get vaccinated.

1 … 40 41 42 43

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

755 stories

University of Newcastle

the American Heart Association

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Democratic Republic of Congo

540 stories

Northern Territory

321 stories

the Democratic Republic of Congo

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.